Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01822015||Active, not recruiting||Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia||
||Early Phase 1||
||55||All||18 Years and older (Adult, Older Adult)||NCT01822015||12D.588
|March 15, 2013||December 2019||June 2020||April 1, 2013||April 24, 2018||